EEG and caffeine timing in premature infants
Part of Lungs & breathing clinical trials.
This study uses EEG brain scans to find the best time to stop caffeine treatment in premature babies. Caffeine is given to help with breathing, and the goal is to see if brain activity can guide when to safely stop it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Babies born before 28 weeks and weighing 1250 grams or less who received caffeine
- Babies born before 32 weeks weighing more than 1250 grams who needed a breathing machine and got caffeine
- Babies born before 37 weeks who were treated with caffeine for breathing pauses in the NICU
- Parents or guardians gave permission for the study
- No major birth defects (like brain, heart, lung, or muscle problems)
- Baby was not transferred to another hospital within 1 week before or after stopping caffeine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether giving caffeine to premature babies helps keep their hearts stable. It may help parents understand if caffeine treatment is safe for their baby's heart.
This trial tests whether giving caffeine citrate can help prevent breathing pauses (apnea) in preterm babies who are ready to stop their current caffeine treatment. It aims to see if a short course of caffeine can keep babies stable after they come off oxygen and are eating well.
This trial tests whether giving caffeine citrate early to very premature babies (born before 32 weeks) improves their breathing and long-term health. It aims to find the best way to use this common medicine to help your baby grow and develop.
This study tests if giving an extra dose of caffeine (a medicine that helps premature babies breathe) right before removing the breathing tube can make the transition easier. It is for very premature babies who have been on a ventilator for at least two days and are ready for their first try at breathing on their own.
This study looks at a new, gentler way to measure caffeine levels in preterm babies using a very small blood sample. The goal is to understand how caffeine moves in your baby's body so doctors can give the right dose with fewer needle sticks.
This study looks at how caffeine is absorbed and transferred to a baby during pregnancy in women at risk of early delivery. Researchers hope to understand safe caffeine use in this situation and potentially help prevent complications.
Hear when a new Apnea Neonatal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.